Krishnaraju Madavaraju

3PUBLICATIONS
7CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 23, 2026
A CDK-4EBP1 signaling axis drives HSV-1 replication and underscores a druggable pathway for potent antiviral intervention.

Krishnaraju Madavaraju, Tejabhiram Yadavalli, Sudhanshu Kumar Singh

|Oct 15, 2021
mTORC2 confers neuroprotection and potentiates immunity during virus infection.

Rahul K Suryawanshi, Chandrashekhar D Patil, Alex Agelidis

|Dec 05, 2020
Standalone or combinatorial phenylbutyrate therapy shows excellent antiviral activity and mimics CREB3 silencing.

Tejabhiram Yadavalli, Rahul Suryawanshi, Raghuram Koganti

Pageof 1